Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Fenofibrate 160 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹199/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Finrate 160 Tablet contains Fenofibrate 160 mg, a fibric acid derivative used to regulate lipid levels in the blood. It activates peroxisome proliferator-activated receptor alpha (PPARα), which increases the oxidation of fatty acids and reduces the levels of triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C), while increasing high-density lipoprotein cholesterol (HDL-C). Fenofibrate is particularly beneficial for patients with hypertriglyceridemia, mixed dyslipidemia, or type 2 diabetes with elevated lipid levels, where statin monotherapy may be insufficient.
Finrate 160 Tablet offers cardiovascular protection by addressing multiple lipid parameters and reducing inflammation markers.
Fenocare 160 is generally well-tolerated. However, some patients may experience gastrointestinal disturbances, muscle cramps, elevated liver enzymes, or increased creatinine levels. Rarely, myopathy, rhabdomyolysis, or gallstone formation may occur.
Fenocare 160 Tablet is indicated for the treatment of severe hypertriglyceridemia, primary hypercholesterolemia, and mixed dyslipidemia. It is especially beneficial in patients with metabolic syndrome, diabetes mellitus, or a high risk of cardiovascular disease. The tablet is often used when dietary management and lifestyle modifications fail to adequately reduce elevated lipid levels or as an adjunct to statin therapy in selected patients needing additional triglyceride control.
This medication should only be used under medical supervision. Liver, kidney, and lipid parameters should be monitored regularly during treatment. Not recommended in patients with severe renal impairment, liver disease, or gallbladder disorders.
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.
Composition : Fenofibrate (145mg) tablet
Composition : Rosuvastatin 10 mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Torsemide 100mg Tablet
Composition : Torsemide 5mg Tablet
Composition : Torsemide 40mg Tablet
Composition : Ticagrelor 90 mg Tablet
Composition : Ticagrelor 90mg 14 Tablet + Aspirin 75mg 7 Tablet Kit
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Fenofibrate 160mg Tablet is a lipid-lowering medicine used for managing high triglycerides and cholesterol levels, making it a strong cardiovascular and chronic-care product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in hypertriglyceridemia, dyslipidemia, and cardiovascular risk management. It is commonly prescribed by cardiologists and physicians for long-term lipid control and heart health support.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Fenofibrate 160mg Tablet with monopoly rights, quality cardiovascular formulations, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from long-term prescription demand, repeat patient usage, and stable cardiology sales when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this lipid-lowering formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.